A mathematical model for chemoimmunotherapy of chronic lymphocytic leukemia
Clicks: 79
ID: 281583
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
23.4
/100
79 views
30 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #403 of 803 articles by views in arXiv
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 803 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Immunotherapy is currently regarded as the most promising treatment to fight
against cancer. This is particularly true in the treatment of chronic
lymphocytic leukemia, an indolent neoplastic disease of B-lymphocytes which
eventually causes the immune system's failure. In this and other areas of
cancer research, mathematical modeling is pointed out as a prominent tool to
analyze theoretical and practical issues. Its lack in studies of
chemoimmunotherapy of chronic lymphocytic leukemia is what motivates us to come
up with a simple ordinary differential equation model. It is based on ideas of
de Pillis & Radunskaya and on standard pharmacokinetics-pharmacodynamics
assumptions. In order to check the positivity of the state variables, we first
establish an invariant region where these time-dependent variables remain
positive. Afterwards, the action of the immune system, as well as the
chemoimmunotherapeutic role in promoting cancer cure are investigated by means
of numerical simulations and the classical linear stability analysis. The role
of adoptive cellular immunotherapy is also addressed. Our overall conclusion is
that chemoimmunotherapeutic protocols can be effective in treating chronic
lymphocytic leukemia provided that chemotherapy is not a limiting factor to the
immunotherapy efficacy.
| Reference Key |
gonçalves2018a
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Diego Samuel Rodrigues; Paulo Fernando de Arruda Mancera; Tiago de Carvalho; Luiz Fernando Gonçalves |
| Journal | arXiv |
| Year | 2018 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.